Le Lézard
Classified in: Health, Science and technology
Subjects: AWD, TDS

Dr. Ge Li Awarded "CEO of the Year" at CPhI Worldwide 2019

SHANGHAI, Nov. 10, 2019 /PRNewswire/ -- WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and medical device industries, announced today that its Chairman and CEO Dr. Ge Li was awarded "CEO of the Year" at the CPhI Worldwide 2019, a top pharmaceutical event uniting over 45,000 professionals worldwide.

The 2019 CPhI Pharma Awards recognize the innovation and dedication of companies and individuals who are driving the pharmaceutical industry forward. Its Judging Panel is comprised of independent, senior industry experts from around the world, each chosen for their knowledge, objectivity and credibility.

Dr. Ge Li was chosen for his significant contribution to the global biopharma R&D industry. "Under his leadership, WuXi AppTec has become a highly respected contributor to global healthcare innovation. The company is enabling more than 3,700 customers and partners in more than 30 countries by offering open-access capabilities and services, accelerating the discovery and development of new medicines for patients around the world."

"I'm honored by this award and its recognition of WuXi's global platform," said Dr. Ge Li, Chairman and CEO of WuXi AppTec. "It's been our great privilege to serve our innovative partners around the world and help bring some of the most needed medicines closer to patients."

About WuXi AppTec

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,700 collaborators from over 30 countries to improve the health of those in need ? and to realize our vision that "every drug can be made and every disease can be treated." Please visit: http://www.wuxiapptec.com


These press releases may also interest you

at 21:27
Daiya Foods Inc. is recalling Daiya brand Classic Vanilla Creme Non-Dairy Frozen Dessert from the marketplace because it contains milk which is not declared on the label. People with an allergy to milk should not consume the recalled product...

at 20:05
The global patient temperature management market is expected to grow by USD 1.09 billion as per Technavio. This marks a significant market growth compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of...

at 18:55
MemoryCare.com, a comprehensive resource for caregivers and older adults living with memory impairment, has announced the Best Memory Care Facilities in Charleston, South Carolina. The guide identifies 5 memory care communities based on location,...

at 17:44
Bird Construction Inc. is pleased to announce the sale of Bird Capital Limited's 20 per cent interest in the P3 concessions responsible for 18 schools and nine childcare facilities in Saskatchewan to its project partner, Concert Infrastructure....

at 17:44
Minnesota-based parkour gym Fight or Flight Academy, is hosting an online parkour competition with a $10,000 prize, the largest prize in parkour history, to help promote the upcoming launch of their online parkour academy.  ...

at 17:31
Winpak Ltd. (the "Corporation") is pleased to announce that the nominees listed in the management proxy circular dated February 21, 2020, were elected as directors of the Corporation at the Corporation's Annual Meeting of Shareholders held virtually...

News published on 10 november 2019 at 19:00 and distributed by: